Onyx Biotec IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

Onyx Biotec IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE
For the Onyx Biotec IPO, the company is issuing shares at a pre-issue EPS of ₹2.54 and a post-issue EPS of ₹1.67. The pre-issue P/E ratio is 24.01x, while the post-issue P/E ratio is 36.52x against the Industry P/E ratio is 75.10x. The company's ROCE for FY24 is 10.58% and RoE for FY24 is 12.19%. These metrics suggest that the IPO is fairly priced.

Key Performance Indicator

KPI Values
EPS Pre IPO (Rs.) ₹2.54
EPS Post IPO (Rs.) ₹1.67
P/E Pre IPO 24.01
P/E Post IPO 36.52
ROE 12.19%
ROCE 10.58%
P/BV 1.99
Debt/Equity 1.24
RoNW 12.19%

Services

Equity Investment with CA Abhay

Stock Market Masterclass

FNO Stocks with CA Abhay

Option Trading with CA Abhay

Equity Trading with CA Abhay

Services

Option Trading with CA Abhay

Equity Trading with CA Abhay

FNO Stocks with CA Abhay

Equity Investment with CA Abhay

Stock Market Masterclass

onlyfans leakedonlyfan leaksonlyfans leaked videos